Advertisement

Index by author

May 01, 2001; Volume 29,Issue 5

A

  1. Abbott, Frank S.

    1. Dose-Dependent Pharmacokinetics and Metabolism of Valproic Acid in Newborn Lambs and Adult Sheep
      Harvey Wong, Dan W. Rurak, Sanjeev Kumar, Eddie Kwan, Frank S. Abbott and K. Wayne Riggs
      Drug Metabolism and Disposition May 2001, 29 (5) 664-675;

  2. Andersson, Tommy B.

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  3. Artur, Yves

    1. Involvement of Semicarbazide-Sensitive Amine Oxidase in Tresperimus Metabolism in Human and in Rat
      Philippe Claud, Paul Padovani, Jean-Pierre Guichard, Yves Artur and Romuald Lainé
      Drug Metabolism and Disposition May 2001, 29 (5) 735-741;

B

  1. Bekersky, Ihor

    1. Biodistribution of 4-[14C]Cholesterol-AmBisome following a Single Intravenous Administration to Rats
      Robert W. Townsend, Anup Zutshi and Ihor Bekersky
      Drug Metabolism and Disposition May 2001, 29 (5) 681-685;

  2. Belpaire, Frans M.

    1. Metoprolol-Paroxetine Interaction in Human Liver Microsomes: Stereoselective Aspects and Prediction of the in Vivo Interaction
      Alex Hemeryck, Cindy A. De Vriendt and Frans M. Belpaire
      Drug Metabolism and Disposition May 2001, 29 (5) 656-663;

  3. Boobis, Alan R.

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  4. Borlak, Jürgen

    1. Verapamil Metabolism in Distinct Regions of the Heart and in Cultures of Cardiomyocytes of Adult Rats
      Markus Walles, Thomas Thum, Karsten Levsen and Jürgen Borlak
      Drug Metabolism and Disposition May 2001, 29 (5) 761-768;

  5. Bras, Alvaro P. M.

    1. Spermidine/SpermineN 1-Acetyltransferase Catalyzes Amantadine Acetylation
      Alvaro P. M. Bras, Juhani Jänne, Carl W. Porter and Daniel S. Sitar
      Drug Metabolism and Disposition May 2001, 29 (5) 676-680;

  6. Brouwer, Kenneth R.

    1. Induction of P-Glycoprotein and Cytochrome P450 3A by HIV Protease Inhibitors
      Liyue Huang, Stephen A. Wring, Joseph L. Woolley, Kenneth R. Brouwer, Cosette Serabjit-Singh and Joseph W. Polli
      Drug Metabolism and Disposition May 2001, 29 (5) 754-760;

  7. Bull, Arthur W.

    1. 13-Hydroxy- and 13-Oxooctadecadienoic acids: Novel Substrates for Human UDP-Glucuronosyltransferases
      Anthony R. Jude, Joanna M. Little, Arthur W. Bull, Izabela Podgorski and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2001, 29 (5) 652-655;

C

  1. Castell, José V.

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  2. Chauret, Nathalie

    1. In Vitro Metabolism of the COX-2 Inhibitor DFU, Including a Novel Glutathione Adduct Rearomatization
      James A. Yergey, Laird A. Trimble, José Silva, Nathalie Chauret, Chun Li, Michel Therien, Erich Grimm and Deborah A. Nicoll-Griffith
      Drug Metabolism and Disposition May 2001, 29 (5) 638-644;

  3. Claud, Philippe

    1. Involvement of Semicarbazide-Sensitive Amine Oxidase in Tresperimus Metabolism in Human and in Rat
      Philippe Claud, Paul Padovani, Jean-Pierre Guichard, Yves Artur and Romuald Lainé
      Drug Metabolism and Disposition May 2001, 29 (5) 735-741;

  4. Corcos, Laurent

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  5. Cresteil, T.

    1. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors
      R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine and C. J. Elferink
      Drug Metabolism and Disposition May 2001, 29 (5) 623-633;

  6. Crooks, Peter A.

    1. Accumulation of Nicotine and Its Metabolites in Rat Brain After Intermittent or Continuous Peripheral Administration of [2′-14C]Nicotine
      Omar A. Ghosheh, Linda P. Dwoskin, Dennis K. Miller and Peter A. Crooks
      Drug Metabolism and Disposition May 2001, 29 (5) 645-651;

D

  1. De Vriendt, Cindy A.

    1. Metoprolol-Paroxetine Interaction in Human Liver Microsomes: Stereoselective Aspects and Prediction of the in Vivo Interaction
      Alex Hemeryck, Cindy A. De Vriendt and Frans M. Belpaire
      Drug Metabolism and Disposition May 2001, 29 (5) 656-663;

  2. Ding, X.

    1. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors
      R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine and C. J. Elferink
      Drug Metabolism and Disposition May 2001, 29 (5) 623-633;

  3. Dwoskin, Linda P.

    1. Accumulation of Nicotine and Its Metabolites in Rat Brain After Intermittent or Continuous Peripheral Administration of [2′-14C]Nicotine
      Omar A. Ghosheh, Linda P. Dwoskin, Dennis K. Miller and Peter A. Crooks
      Drug Metabolism and Disposition May 2001, 29 (5) 645-651;

E

  1. Edsbäcker, Staffan

    1. Pharmacokinetics of Budesonide and Its Major Ester Metabolite after Inhalation and Intravenous Administration of Budesonide in the Rat
      Magnus Jendbro, Carl-Johan Johansson, Per Strandberg, Hanna Falk-Nilsson and Staffan Edsbäcker
      Drug Metabolism and Disposition May 2001, 29 (5) 769-776;

  2. Edwards, Robert J.

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  3. Elferink, C. J.

    1. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors
      R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine and C. J. Elferink
      Drug Metabolism and Disposition May 2001, 29 (5) 623-633;

F

  1. Falk-Nilsson, Hanna

    1. Pharmacokinetics of Budesonide and Its Major Ester Metabolite after Inhalation and Intravenous Administration of Budesonide in the Rat
      Magnus Jendbro, Carl-Johan Johansson, Per Strandberg, Hanna Falk-Nilsson and Staffan Edsbäcker
      Drug Metabolism and Disposition May 2001, 29 (5) 769-776;

  2. Falkner, K. C.

    1. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors
      R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine and C. J. Elferink
      Drug Metabolism and Disposition May 2001, 29 (5) 623-633;

  3. Favreau, Leonard V.

    1. Inhibition of CYP3A4 in a Rapid Microtiter Plate Assay Using Recombinant Enzyme and in Human Liver Microsomes Using Conventional Substrates
      Amin A. Nomeir, Charles Ruegg, Matthew Shoemaker, Leonard V. Favreau, Jairam R. Palamanda, Paul Silber and Chin-chung Lin
      Drug Metabolism and Disposition May 2001, 29 (5) 748-753;

  4. Fitzpatrick, J. L.

    1. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors
      R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine and C. J. Elferink
      Drug Metabolism and Disposition May 2001, 29 (5) 623-633;

G

  1. Ge, N.-L.

    1. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors
      R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine and C. J. Elferink
      Drug Metabolism and Disposition May 2001, 29 (5) 623-633;

  2. Ghosheh, Omar A.

    1. Accumulation of Nicotine and Its Metabolites in Rat Brain After Intermittent or Continuous Peripheral Administration of [2′-14C]Nicotine
      Omar A. Ghosheh, Linda P. Dwoskin, Dennis K. Miller and Peter A. Crooks
      Drug Metabolism and Disposition May 2001, 29 (5) 645-651;

  3. Goldfarb, Peter S.

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  4. Gómez-Lechón, Maria J.

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  5. Green, Mitchell D.

    1. Epirubicin Glucuronidation Is Catalyzed by Human UDP-Glucuronosyltransferase 2B7
      Federico Innocenti, Lalitha Iyer, Jacqueline Ramı́rez, Mitchell D. Green and Mark J. Ratain
      Drug Metabolism and Disposition May 2001, 29 (5) 686-692;

  6. Grimm, Erich

    1. In Vitro Metabolism of the COX-2 Inhibitor DFU, Including a Novel Glutathione Adduct Rearomatization
      James A. Yergey, Laird A. Trimble, José Silva, Nathalie Chauret, Chun Li, Michel Therien, Erich Grimm and Deborah A. Nicoll-Griffith
      Drug Metabolism and Disposition May 2001, 29 (5) 638-644;

  7. Guichard, Jean-Pierre

    1. Involvement of Semicarbazide-Sensitive Amine Oxidase in Tresperimus Metabolism in Human and in Rat
      Philippe Claud, Paul Padovani, Jean-Pierre Guichard, Yves Artur and Romuald Lainé
      Drug Metabolism and Disposition May 2001, 29 (5) 735-741;

  8. Guillouzo, André

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  9. Guzelian, Philip S.

    1. CYP3A Regulation: From Pharmacology to Nuclear Receptors
      Linda C. Quattrochi and Philip S. Guzelian
      Drug Metabolism and Disposition May 2001, 29 (5) 615-622;

H

  1. He, Minxia

    1. Metabolism of Sulfinpyrazone Sulfide and Sulfinpyrazone by Human Liver Microsomes and cDNA-Expressed Cytochrome P450s
      Minxia He, Allan E. Rettie, John Neal and William F. Trager
      Drug Metabolism and Disposition May 2001, 29 (5) 701-711;

  2. Hee, Brian

    1. Liquid Chromatography-Mass Spectrometry and Liquid Chromatography-NMR Characterization of in Vitro Metabolites of a Potent and Irreversible Peptidomimetic Inhibitor of Rhinovirus 3C Protease
      Kanyin E. Zhang, Brian Hee, Caroline A. Lee, Baihong Liang and Barbara C. M. Potts
      Drug Metabolism and Disposition May 2001, 29 (5) 729-734;

  3. Hemeryck, Alex

    1. Metoprolol-Paroxetine Interaction in Human Liver Microsomes: Stereoselective Aspects and Prediction of the in Vivo Interaction
      Alex Hemeryck, Cindy A. De Vriendt and Frans M. Belpaire
      Drug Metabolism and Disposition May 2001, 29 (5) 656-663;

  4. Hidestrand, Mats

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  5. Hines, R. N.

    1. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors
      R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine and C. J. Elferink
      Drug Metabolism and Disposition May 2001, 29 (5) 623-633;

  6. Hoffmann, Kurt-Jürgen

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  7. Huang, Liyue

    1. Multidrug Resistance P-Glycoprotein 2 Is Essential for the Biliary Excretion of Indocyanine Green
      Liyue Huang and Mary Vore
      Drug Metabolism and Disposition May 2001, 29 (5) 634-637;
    2. Induction of P-Glycoprotein and Cytochrome P450 3A by HIV Protease Inhibitors
      Liyue Huang, Stephen A. Wring, Joseph L. Woolley, Kenneth R. Brouwer, Cosette Serabjit-Singh and Joseph W. Polli
      Drug Metabolism and Disposition May 2001, 29 (5) 754-760;

I

  1. Ingelman-Sundberg, Magnus

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  2. Innocenti, Federico

    1. Epirubicin Glucuronidation Is Catalyzed by Human UDP-Glucuronosyltransferase 2B7
      Federico Innocenti, Lalitha Iyer, Jacqueline Ramı́rez, Mitchell D. Green and Mark J. Ratain
      Drug Metabolism and Disposition May 2001, 29 (5) 686-692;

  3. Iyer, Lalitha

    1. Epirubicin Glucuronidation Is Catalyzed by Human UDP-Glucuronosyltransferase 2B7
      Federico Innocenti, Lalitha Iyer, Jacqueline Ramı́rez, Mitchell D. Green and Mark J. Ratain
      Drug Metabolism and Disposition May 2001, 29 (5) 686-692;

J

  1. James, Margaret O.

    1. Intestinal Bioavailability and Biotransformation of 3-Hydroxybenzo(a)pyrene in an Isolated Perfused Preparation from Channel Catfish, Ictalurus punctatus
      Margaret O. James, Zeen Tong, Laura Rowland-Faux, Changaram S. Venugopal and Kevin M. Kleinow
      Drug Metabolism and Disposition May 2001, 29 (5) 721-728;

  2. Jänne, Juhani

    1. Spermidine/SpermineN 1-Acetyltransferase Catalyzes Amantadine Acetylation
      Alvaro P. M. Bras, Juhani Jänne, Carl W. Porter and Daniel S. Sitar
      Drug Metabolism and Disposition May 2001, 29 (5) 676-680;

  3. Jendbro, Magnus

    1. Pharmacokinetics of Budesonide and Its Major Ester Metabolite after Inhalation and Intravenous Administration of Budesonide in the Rat
      Magnus Jendbro, Carl-Johan Johansson, Per Strandberg, Hanna Falk-Nilsson and Staffan Edsbäcker
      Drug Metabolism and Disposition May 2001, 29 (5) 769-776;

  4. Johansson, Carl-Johan

    1. Pharmacokinetics of Budesonide and Its Major Ester Metabolite after Inhalation and Intravenous Administration of Budesonide in the Rat
      Magnus Jendbro, Carl-Johan Johansson, Per Strandberg, Hanna Falk-Nilsson and Staffan Edsbäcker
      Drug Metabolism and Disposition May 2001, 29 (5) 769-776;

  5. Jude, Anthony R.

    1. 13-Hydroxy- and 13-Oxooctadecadienoic acids: Novel Substrates for Human UDP-Glucuronosyltransferases
      Anthony R. Jude, Joanna M. Little, Arthur W. Bull, Izabela Podgorski and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2001, 29 (5) 652-655;

K

  1. Kleinow, Kevin M.

    1. Intestinal Bioavailability and Biotransformation of 3-Hydroxybenzo(a)pyrene in an Isolated Perfused Preparation from Channel Catfish, Ictalurus punctatus
      Margaret O. James, Zeen Tong, Laura Rowland-Faux, Changaram S. Venugopal and Kevin M. Kleinow
      Drug Metabolism and Disposition May 2001, 29 (5) 721-728;

  2. Krueger, Sharon K.

    1. Characterization of Expressed Full-Length and Truncated FMO2 from Rhesus Monkey
      Sharon K. Krueger, Mei-Fei Yueh, Sarah R. Martin, Clifford B. Pereira and David E. Williams
      Drug Metabolism and Disposition May 2001, 29 (5) 693-700;

  3. Kumar, Sanjeev

    1. Dose-Dependent Pharmacokinetics and Metabolism of Valproic Acid in Newborn Lambs and Adult Sheep
      Harvey Wong, Dan W. Rurak, Sanjeev Kumar, Eddie Kwan, Frank S. Abbott and K. Wayne Riggs
      Drug Metabolism and Disposition May 2001, 29 (5) 664-675;

  4. Kwan, Eddie

    1. Dose-Dependent Pharmacokinetics and Metabolism of Valproic Acid in Newborn Lambs and Adult Sheep
      Harvey Wong, Dan W. Rurak, Sanjeev Kumar, Eddie Kwan, Frank S. Abbott and K. Wayne Riggs
      Drug Metabolism and Disposition May 2001, 29 (5) 664-675;

L

  1. Lainé, Romuald

    1. Involvement of Semicarbazide-Sensitive Amine Oxidase in Tresperimus Metabolism in Human and in Rat
      Philippe Claud, Paul Padovani, Jean-Pierre Guichard, Yves Artur and Romuald Lainé
      Drug Metabolism and Disposition May 2001, 29 (5) 735-741;

  2. Lake, Brian G.

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  3. Lampen, Alfonso

    1. Effects of Receptor-Selective Retinoids on CYP26 Gene Expression and Metabolism of All-trans-Retinoic Acid in Intestinal Cells
      Alfonso Lampen, Silke Meyer and Heinz Nau
      Drug Metabolism and Disposition May 2001, 29 (5) 742-747;

  4. Lee, Caroline A.

    1. Liquid Chromatography-Mass Spectrometry and Liquid Chromatography-NMR Characterization of in Vitro Metabolites of a Potent and Irreversible Peptidomimetic Inhibitor of Rhinovirus 3C Protease
      Kanyin E. Zhang, Brian Hee, Caroline A. Lee, Baihong Liang and Barbara C. M. Potts
      Drug Metabolism and Disposition May 2001, 29 (5) 729-734;

  5. Levine, A.

    1. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors
      R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine and C. J. Elferink
      Drug Metabolism and Disposition May 2001, 29 (5) 623-633;

  6. Levsen, Karsten

    1. Verapamil Metabolism in Distinct Regions of the Heart and in Cultures of Cardiomyocytes of Adult Rats
      Markus Walles, Thomas Thum, Karsten Levsen and Jürgen Borlak
      Drug Metabolism and Disposition May 2001, 29 (5) 761-768;

  7. Lewis, David F. V.

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  8. Li, Chun

    1. In Vitro Metabolism of the COX-2 Inhibitor DFU, Including a Novel Glutathione Adduct Rearomatization
      James A. Yergey, Laird A. Trimble, José Silva, Nathalie Chauret, Chun Li, Michel Therien, Erich Grimm and Deborah A. Nicoll-Griffith
      Drug Metabolism and Disposition May 2001, 29 (5) 638-644;

  9. Liang, Baihong

    1. Liquid Chromatography-Mass Spectrometry and Liquid Chromatography-NMR Characterization of in Vitro Metabolites of a Potent and Irreversible Peptidomimetic Inhibitor of Rhinovirus 3C Protease
      Kanyin E. Zhang, Brian Hee, Caroline A. Lee, Baihong Liang and Barbara C. M. Potts
      Drug Metabolism and Disposition May 2001, 29 (5) 729-734;

  10. Lin, Chin-chung

    1. Inhibition of CYP3A4 in a Rapid Microtiter Plate Assay Using Recombinant Enzyme and in Human Liver Microsomes Using Conventional Substrates
      Amin A. Nomeir, Charles Ruegg, Matthew Shoemaker, Leonard V. Favreau, Jairam R. Palamanda, Paul Silber and Chin-chung Lin
      Drug Metabolism and Disposition May 2001, 29 (5) 748-753;

  11. Little, Joanna M.

    1. 13-Hydroxy- and 13-Oxooctadecadienoic acids: Novel Substrates for Human UDP-Glucuronosyltransferases
      Anthony R. Jude, Joanna M. Little, Arthur W. Bull, Izabela Podgorski and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2001, 29 (5) 652-655;

  12. Luo, Z.

    1. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors
      R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine and C. J. Elferink
      Drug Metabolism and Disposition May 2001, 29 (5) 623-633;

M

  1. Martin, Sarah R.

    1. Characterization of Expressed Full-Length and Truncated FMO2 from Rhesus Monkey
      Sharon K. Krueger, Mei-Fei Yueh, Sarah R. Martin, Clifford B. Pereira and David E. Williams
      Drug Metabolism and Disposition May 2001, 29 (5) 693-700;

  2. Meyer, Silke

    1. Effects of Receptor-Selective Retinoids on CYP26 Gene Expression and Metabolism of All-trans-Retinoic Acid in Intestinal Cells
      Alfonso Lampen, Silke Meyer and Heinz Nau
      Drug Metabolism and Disposition May 2001, 29 (5) 742-747;

  3. Miller, Dennis K.

    1. Accumulation of Nicotine and Its Metabolites in Rat Brain After Intermittent or Continuous Peripheral Administration of [2′-14C]Nicotine
      Omar A. Ghosheh, Linda P. Dwoskin, Dennis K. Miller and Peter A. Crooks
      Drug Metabolism and Disposition May 2001, 29 (5) 645-651;

N

  1. Nau, Heinz

    1. Effects of Receptor-Selective Retinoids on CYP26 Gene Expression and Metabolism of All-trans-Retinoic Acid in Intestinal Cells
      Alfonso Lampen, Silke Meyer and Heinz Nau
      Drug Metabolism and Disposition May 2001, 29 (5) 742-747;

  2. Neal, John

    1. Metabolism of Sulfinpyrazone Sulfide and Sulfinpyrazone by Human Liver Microsomes and cDNA-Expressed Cytochrome P450s
      Minxia He, Allan E. Rettie, John Neal and William F. Trager
      Drug Metabolism and Disposition May 2001, 29 (5) 701-711;

  3. Nicoll-Griffith, Deborah A.

    1. In Vitro Metabolism of the COX-2 Inhibitor DFU, Including a Novel Glutathione Adduct Rearomatization
      James A. Yergey, Laird A. Trimble, José Silva, Nathalie Chauret, Chun Li, Michel Therien, Erich Grimm and Deborah A. Nicoll-Griffith
      Drug Metabolism and Disposition May 2001, 29 (5) 638-644;

  4. Nomeir, Amin A.

    1. Inhibition of CYP3A4 in a Rapid Microtiter Plate Assay Using Recombinant Enzyme and in Human Liver Microsomes Using Conventional Substrates
      Amin A. Nomeir, Charles Ruegg, Matthew Shoemaker, Leonard V. Favreau, Jairam R. Palamanda, Paul Silber and Chin-chung Lin
      Drug Metabolism and Disposition May 2001, 29 (5) 748-753;

P

  1. Padovani, Paul

    1. Involvement of Semicarbazide-Sensitive Amine Oxidase in Tresperimus Metabolism in Human and in Rat
      Philippe Claud, Paul Padovani, Jean-Pierre Guichard, Yves Artur and Romuald Lainé
      Drug Metabolism and Disposition May 2001, 29 (5) 735-741;

  2. Palamanda, Jairam R.

    1. Inhibition of CYP3A4 in a Rapid Microtiter Plate Assay Using Recombinant Enzyme and in Human Liver Microsomes Using Conventional Substrates
      Amin A. Nomeir, Charles Ruegg, Matthew Shoemaker, Leonard V. Favreau, Jairam R. Palamanda, Paul Silber and Chin-chung Lin
      Drug Metabolism and Disposition May 2001, 29 (5) 748-753;

  3. Pelkonen, Olavi

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  4. Pereira, Clifford B.

    1. Characterization of Expressed Full-Length and Truncated FMO2 from Rhesus Monkey
      Sharon K. Krueger, Mei-Fei Yueh, Sarah R. Martin, Clifford B. Pereira and David E. Williams
      Drug Metabolism and Disposition May 2001, 29 (5) 693-700;

  5. Podgorski, Izabela

    1. 13-Hydroxy- and 13-Oxooctadecadienoic acids: Novel Substrates for Human UDP-Glucuronosyltransferases
      Anthony R. Jude, Joanna M. Little, Arthur W. Bull, Izabela Podgorski and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2001, 29 (5) 652-655;

  6. Polli, Joseph W.

    1. Induction of P-Glycoprotein and Cytochrome P450 3A by HIV Protease Inhibitors
      Liyue Huang, Stephen A. Wring, Joseph L. Woolley, Kenneth R. Brouwer, Cosette Serabjit-Singh and Joseph W. Polli
      Drug Metabolism and Disposition May 2001, 29 (5) 754-760;

  7. Porter, Carl W.

    1. Spermidine/SpermineN 1-Acetyltransferase Catalyzes Amantadine Acetylation
      Alvaro P. M. Bras, Juhani Jänne, Carl W. Porter and Daniel S. Sitar
      Drug Metabolism and Disposition May 2001, 29 (5) 676-680;

  8. Potts, Barbara C. M.

    1. Liquid Chromatography-Mass Spectrometry and Liquid Chromatography-NMR Characterization of in Vitro Metabolites of a Potent and Irreversible Peptidomimetic Inhibitor of Rhinovirus 3C Protease
      Kanyin E. Zhang, Brian Hee, Caroline A. Lee, Baihong Liang and Barbara C. M. Potts
      Drug Metabolism and Disposition May 2001, 29 (5) 729-734;

  9. Price, Roger J.

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  10. Prough, R. A.

    1. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors
      R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine and C. J. Elferink
      Drug Metabolism and Disposition May 2001, 29 (5) 623-633;

Q

  1. Quattrochi, Linda C.

    1. CYP3A Regulation: From Pharmacology to Nuclear Receptors
      Linda C. Quattrochi and Philip S. Guzelian
      Drug Metabolism and Disposition May 2001, 29 (5) 615-622;

R

  1. Radominska-Pandya, Anna

    1. 13-Hydroxy- and 13-Oxooctadecadienoic acids: Novel Substrates for Human UDP-Glucuronosyltransferases
      Anthony R. Jude, Joanna M. Little, Arthur W. Bull, Izabela Podgorski and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2001, 29 (5) 652-655;

  2. Ramı́rez, Jacqueline

    1. Epirubicin Glucuronidation Is Catalyzed by Human UDP-Glucuronosyltransferase 2B7
      Federico Innocenti, Lalitha Iyer, Jacqueline Ramı́rez, Mitchell D. Green and Mark J. Ratain
      Drug Metabolism and Disposition May 2001, 29 (5) 686-692;

  3. Ratain, Mark J.

    1. Epirubicin Glucuronidation Is Catalyzed by Human UDP-Glucuronosyltransferase 2B7
      Federico Innocenti, Lalitha Iyer, Jacqueline Ramı́rez, Mitchell D. Green and Mark J. Ratain
      Drug Metabolism and Disposition May 2001, 29 (5) 686-692;

  4. Renwick, Anthony B.

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  5. Rettie, Allan E.

    1. Metabolism of Sulfinpyrazone Sulfide and Sulfinpyrazone by Human Liver Microsomes and cDNA-Expressed Cytochrome P450s
      Minxia He, Allan E. Rettie, John Neal and William F. Trager
      Drug Metabolism and Disposition May 2001, 29 (5) 701-711;

  6. Riggs, K. Wayne

    1. Dose-Dependent Pharmacokinetics and Metabolism of Valproic Acid in Newborn Lambs and Adult Sheep
      Harvey Wong, Dan W. Rurak, Sanjeev Kumar, Eddie Kwan, Frank S. Abbott and K. Wayne Riggs
      Drug Metabolism and Disposition May 2001, 29 (5) 664-675;

  7. Ripp, S. L.

    1. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors
      R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine and C. J. Elferink
      Drug Metabolism and Disposition May 2001, 29 (5) 623-633;

  8. Rowland-Faux, Laura

    1. Intestinal Bioavailability and Biotransformation of 3-Hydroxybenzo(a)pyrene in an Isolated Perfused Preparation from Channel Catfish, Ictalurus punctatus
      Margaret O. James, Zeen Tong, Laura Rowland-Faux, Changaram S. Venugopal and Kevin M. Kleinow
      Drug Metabolism and Disposition May 2001, 29 (5) 721-728;

  9. Ruegg, Charles

    1. Inhibition of CYP3A4 in a Rapid Microtiter Plate Assay Using Recombinant Enzyme and in Human Liver Microsomes Using Conventional Substrates
      Amin A. Nomeir, Charles Ruegg, Matthew Shoemaker, Leonard V. Favreau, Jairam R. Palamanda, Paul Silber and Chin-chung Lin
      Drug Metabolism and Disposition May 2001, 29 (5) 748-753;

  10. Rurak, Dan W.

    1. Dose-Dependent Pharmacokinetics and Metabolism of Valproic Acid in Newborn Lambs and Adult Sheep
      Harvey Wong, Dan W. Rurak, Sanjeev Kumar, Eddie Kwan, Frank S. Abbott and K. Wayne Riggs
      Drug Metabolism and Disposition May 2001, 29 (5) 664-675;

S

  1. Serabjit-Singh, Cosette

    1. Induction of P-Glycoprotein and Cytochrome P450 3A by HIV Protease Inhibitors
      Liyue Huang, Stephen A. Wring, Joseph L. Woolley, Kenneth R. Brouwer, Cosette Serabjit-Singh and Joseph W. Polli
      Drug Metabolism and Disposition May 2001, 29 (5) 754-760;

  2. Shoemaker, Matthew

    1. Inhibition of CYP3A4 in a Rapid Microtiter Plate Assay Using Recombinant Enzyme and in Human Liver Microsomes Using Conventional Substrates
      Amin A. Nomeir, Charles Ruegg, Matthew Shoemaker, Leonard V. Favreau, Jairam R. Palamanda, Paul Silber and Chin-chung Lin
      Drug Metabolism and Disposition May 2001, 29 (5) 748-753;

  3. Silber, Paul

    1. Inhibition of CYP3A4 in a Rapid Microtiter Plate Assay Using Recombinant Enzyme and in Human Liver Microsomes Using Conventional Substrates
      Amin A. Nomeir, Charles Ruegg, Matthew Shoemaker, Leonard V. Favreau, Jairam R. Palamanda, Paul Silber and Chin-chung Lin
      Drug Metabolism and Disposition May 2001, 29 (5) 748-753;

  4. Silva, José

    1. In Vitro Metabolism of the COX-2 Inhibitor DFU, Including a Novel Glutathione Adduct Rearomatization
      James A. Yergey, Laird A. Trimble, José Silva, Nathalie Chauret, Chun Li, Michel Therien, Erich Grimm and Deborah A. Nicoll-Griffith
      Drug Metabolism and Disposition May 2001, 29 (5) 638-644;

  5. Sitar, Daniel S.

    1. Spermidine/SpermineN 1-Acetyltransferase Catalyzes Amantadine Acetylation
      Alvaro P. M. Bras, Juhani Jänne, Carl W. Porter and Daniel S. Sitar
      Drug Metabolism and Disposition May 2001, 29 (5) 676-680;

  6. Sjöberg, Helena

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  7. Strandberg, Per

    1. Pharmacokinetics of Budesonide and Its Major Ester Metabolite after Inhalation and Intravenous Administration of Budesonide in the Rat
      Magnus Jendbro, Carl-Johan Johansson, Per Strandberg, Hanna Falk-Nilsson and Staffan Edsbäcker
      Drug Metabolism and Disposition May 2001, 29 (5) 769-776;

T

  1. Taavitsainen, Päivi

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  2. Therien, Michel

    1. In Vitro Metabolism of the COX-2 Inhibitor DFU, Including a Novel Glutathione Adduct Rearomatization
      James A. Yergey, Laird A. Trimble, José Silva, Nathalie Chauret, Chun Li, Michel Therien, Erich Grimm and Deborah A. Nicoll-Griffith
      Drug Metabolism and Disposition May 2001, 29 (5) 638-644;

  3. Thum, Thomas

    1. Verapamil Metabolism in Distinct Regions of the Heart and in Cultures of Cardiomyocytes of Adult Rats
      Markus Walles, Thomas Thum, Karsten Levsen and Jürgen Borlak
      Drug Metabolism and Disposition May 2001, 29 (5) 761-768;

  4. Tong, Zeen

    1. Intestinal Bioavailability and Biotransformation of 3-Hydroxybenzo(a)pyrene in an Isolated Perfused Preparation from Channel Catfish, Ictalurus punctatus
      Margaret O. James, Zeen Tong, Laura Rowland-Faux, Changaram S. Venugopal and Kevin M. Kleinow
      Drug Metabolism and Disposition May 2001, 29 (5) 721-728;

  5. Townsend, Robert W.

    1. Biodistribution of 4-[14C]Cholesterol-AmBisome following a Single Intravenous Administration to Rats
      Robert W. Townsend, Anup Zutshi and Ihor Bekersky
      Drug Metabolism and Disposition May 2001, 29 (5) 681-685;

  6. Trager, William F.

    1. Metabolism of Sulfinpyrazone Sulfide and Sulfinpyrazone by Human Liver Microsomes and cDNA-Expressed Cytochrome P450s
      Minxia He, Allan E. Rettie, John Neal and William F. Trager
      Drug Metabolism and Disposition May 2001, 29 (5) 701-711;

  7. Trimble, Laird A.

    1. In Vitro Metabolism of the COX-2 Inhibitor DFU, Including a Novel Glutathione Adduct Rearomatization
      James A. Yergey, Laird A. Trimble, José Silva, Nathalie Chauret, Chun Li, Michel Therien, Erich Grimm and Deborah A. Nicoll-Griffith
      Drug Metabolism and Disposition May 2001, 29 (5) 638-644;

V

  1. Venugopal, Changaram S.

    1. Intestinal Bioavailability and Biotransformation of 3-Hydroxybenzo(a)pyrene in an Isolated Perfused Preparation from Channel Catfish, Ictalurus punctatus
      Margaret O. James, Zeen Tong, Laura Rowland-Faux, Changaram S. Venugopal and Kevin M. Kleinow
      Drug Metabolism and Disposition May 2001, 29 (5) 721-728;

  2. Vore, Mary

    1. Multidrug Resistance P-Glycoprotein 2 Is Essential for the Biliary Excretion of Indocyanine Green
      Liyue Huang and Mary Vore
      Drug Metabolism and Disposition May 2001, 29 (5) 634-637;

W

  1. Walles, Markus

    1. Verapamil Metabolism in Distinct Regions of the Heart and in Cultures of Cardiomyocytes of Adult Rats
      Markus Walles, Thomas Thum, Karsten Levsen and Jürgen Borlak
      Drug Metabolism and Disposition May 2001, 29 (5) 761-768;

  2. Watts, Patricia

    1. An Assessment of Human Liver-Derived in Vitro Systems to Predict the in Vivo Metabolism and Clearance of Almokalant
      Tommy B. Andersson, Helena Sjöberg, Kurt-Jürgen Hoffmann, Alan R. Boobis, Patricia Watts, Robert J. Edwards, Brian G. Lake, Roger J. Price, Anthony B. Renwick, Maria J. Gómez-Lechón, José V. Castell, Magnus Ingelman-Sundberg, Mats Hidestrand, Peter S. Goldfarb, David F. V. Lewis, Laurent Corcos, André Guillouzo, Päivi Taavitsainen and Olavi Pelkonen
      Drug Metabolism and Disposition May 2001, 29 (5) 712-720;

  3. Williams, David E.

    1. Characterization of Expressed Full-Length and Truncated FMO2 from Rhesus Monkey
      Sharon K. Krueger, Mei-Fei Yueh, Sarah R. Martin, Clifford B. Pereira and David E. Williams
      Drug Metabolism and Disposition May 2001, 29 (5) 693-700;

  4. Wong, Harvey

    1. Dose-Dependent Pharmacokinetics and Metabolism of Valproic Acid in Newborn Lambs and Adult Sheep
      Harvey Wong, Dan W. Rurak, Sanjeev Kumar, Eddie Kwan, Frank S. Abbott and K. Wayne Riggs
      Drug Metabolism and Disposition May 2001, 29 (5) 664-675;

  5. Woolley, Joseph L.

    1. Induction of P-Glycoprotein and Cytochrome P450 3A by HIV Protease Inhibitors
      Liyue Huang, Stephen A. Wring, Joseph L. Woolley, Kenneth R. Brouwer, Cosette Serabjit-Singh and Joseph W. Polli
      Drug Metabolism and Disposition May 2001, 29 (5) 754-760;

  6. Wring, Stephen A.

    1. Induction of P-Glycoprotein and Cytochrome P450 3A by HIV Protease Inhibitors
      Liyue Huang, Stephen A. Wring, Joseph L. Woolley, Kenneth R. Brouwer, Cosette Serabjit-Singh and Joseph W. Polli
      Drug Metabolism and Disposition May 2001, 29 (5) 754-760;

Y

  1. Yeleswaram, Swamy

    1. Probenecid-Associated Alterations in Valproic Acid Pharmacokinetics in Rats: Can in Vivo Disposition of Valproate Glucuronide Be Predicted from in Vitro Formation Data?
      Swamy Yeleswaram
      Drug Metabolism and Disposition May 2001, 29 (5) 777;

  2. Yergey, James A.

    1. In Vitro Metabolism of the COX-2 Inhibitor DFU, Including a Novel Glutathione Adduct Rearomatization
      James A. Yergey, Laird A. Trimble, José Silva, Nathalie Chauret, Chun Li, Michel Therien, Erich Grimm and Deborah A. Nicoll-Griffith
      Drug Metabolism and Disposition May 2001, 29 (5) 638-644;

  3. Yueh, Mei-Fei

    1. Characterization of Expressed Full-Length and Truncated FMO2 from Rhesus Monkey
      Sharon K. Krueger, Mei-Fei Yueh, Sarah R. Martin, Clifford B. Pereira and David E. Williams
      Drug Metabolism and Disposition May 2001, 29 (5) 693-700;

Z

  1. Zhang, Kanyin E.

    1. Liquid Chromatography-Mass Spectrometry and Liquid Chromatography-NMR Characterization of in Vitro Metabolites of a Potent and Irreversible Peptidomimetic Inhibitor of Rhinovirus 3C Protease
      Kanyin E. Zhang, Brian Hee, Caroline A. Lee, Baihong Liang and Barbara C. M. Potts
      Drug Metabolism and Disposition May 2001, 29 (5) 729-734;

  2. Zutshi, Anup

    1. Biodistribution of 4-[14C]Cholesterol-AmBisome following a Single Intravenous Administration to Rats
      Robert W. Townsend, Anup Zutshi and Ihor Bekersky
      Drug Metabolism and Disposition May 2001, 29 (5) 681-685;
Back to top

In this issue

Advertisement